Marta Żołnowska

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 868 citations

Placebo-controlled Phase 3, Neuropharmacology, Pharmacotherapy +4

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial

Orrin Devinsky, Rima Nabbout, Ian Miller et al. · Epilepsia · 2018 · 265 citations · Full text

Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

Ingrid E. Scheffer, Jonathan J. Halford, Ian Miller et al. · Epilepsia · 2021 · 87 citations · Full text

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (<scp>ELEKTRA</scp>)

Cecil D. Hahn, Yuwu Jiang, Vicente Villanueva et al. · Epilepsia · 2022 · 71 citations · Full text

Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

Yvan Vandenplas, Marta Żołnowska, Roberto Berni Canani et al. · Nutrients · 2022 · 45 citations · Full text